| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 10.214 | 25.604 | 27.261 | 33.522 | 33.175 | 32.228 | 37.095 | 48.277 | 52.642 |
| Total Income - EUR | - | 10.214 | 25.608 | 27.262 | 33.522 | 34.209 | 33.239 | 37.096 | 48.278 | 52.643 |
| Total Expenses - EUR | - | 4.508 | 10.382 | 10.793 | 11.026 | 12.727 | 15.628 | 14.534 | 17.434 | 19.747 |
| Gross Profit/Loss - EUR | - | 5.706 | 15.225 | 16.469 | 22.496 | 21.482 | 17.611 | 22.562 | 30.844 | 32.896 |
| Net Profit/Loss - EUR | - | 5.501 | 14.969 | 16.196 | 22.161 | 21.157 | 17.416 | 22.198 | 30.419 | 31.348 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Valfitomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 255 | 125 | 123 | 121 | 843 | 731 | 640 | 544 | 448 |
| Current Assets | - | 5.818 | 17.814 | 18.574 | 26.247 | 29.761 | 22.607 | 22.757 | 39.217 | 33.151 |
| Inventories | - | 0 | 0 | 0 | 2 | 13 | 4 | 0 | 0 | 40 |
| Receivables | - | 1.775 | 3.695 | 4.346 | 5.704 | 4.987 | 5.717 | 7.222 | 11.791 | 8.184 |
| Cash | - | 4.043 | 14.119 | 14.228 | 20.541 | 24.761 | 16.885 | 15.535 | 27.426 | 24.927 |
| Shareholders Funds | - | 5.546 | 15.013 | 18.040 | 23.415 | 29.656 | 22.157 | 22.247 | 38.447 | 25.365 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 526 | 2.926 | 657 | 2.953 | 1.009 | 1.212 | 1.152 | 1.315 | 8.234 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Valfitomed Srl